At what age is ovarian cancer most commonly diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peak Age of Ovarian Cancer

Ovarian cancer incidence peaks in the eighth decade of life, specifically between ages 70-74 years, with an age-specific incidence of 57 per 100,000 women per year. 1

Age Distribution Pattern

The incidence of ovarian cancer follows a clear age-related pattern:

  • Median age at diagnosis is 63 years 1, 2
  • Peak incidence occurs in the eighth decade (ages 70-79 years), with the highest rates specifically between ages 70-74 years 1
  • More than 80% of cases are diagnosed in women over age 50 1, 3
  • Nearly half (48%) of all ovarian cancers occur in women aged 65 years and older 4

Clinical Implications by Age Group

Postmenopausal Women (Standard Pattern)

  • The vast majority of epithelial ovarian cancers occur in postmenopausal women, with incidence rates increasing steeply after age 40 and continuing to rise through the seventh and eighth decades 1, 5
  • Age-adjusted rates peak at 54.0 per 100,000 in the 75-79 year age group 4

Younger Women (Alternative Histologies)

  • Germ cell tumors predominantly affect women between ages 10-30 years and carry a better prognosis 3
  • Sex cord stromal tumors can occur in younger women and are more likely to be diagnosed at early stage 3

Hereditary Cases (Earlier Onset)

  • Women with BRCA1/2 mutations develop ovarian cancer approximately 10 years earlier than those with sporadic disease 1, 3
  • BRCA1 mutations confer a 15-45% lifetime risk, while BRCA2 mutations confer a 10-20% lifetime risk 1, 3
  • Consider genetic testing regardless of family history, as nearly half of BRCA mutation carriers lack a reported family history of cancer 1, 3

Important Caveats

Older women are frequently undertreated despite ovarian cancer being predominantly a disease of the elderly, with mortality declining only 2.2% in elderly women compared to 21.7% in younger women over the past decade 6. This undertreatment occurs even though older women can benefit from standard cytoreductive surgery and chemotherapy combinations 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.